Huntington Ingalls Industries, Inc. Common Stock (NY:HII)

268.54 -5.79 (-2.11%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Huntington Ingalls Industries, Inc. Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

3 Fundamentally Sound Mid-Caps to Keep on the Watch List

October 24, 2022

The mid-cap space is a great place to find less prominent names with the financials to outperform. Watch lists should include these three stocks.

Via MarketBeat

Topics Economy

HII Honors Employees with Inaugural Compass Award for Compliance

October 14, 2022

From Huntington Ingalls Industries, Inc.

Via GlobeNewswire

Huntington Ingalls Bags $76.7M Order From US Air Force ↗

October 12, 2022

Via Benzinga

Credit Suisse Picks 7 Aerospace, Defense Stocks To Buy — And 4 To Avoid ↗

October 12, 2022

Aerospace and defense stocks have been among the handful of investments that have performed well in a very difficult market in 2022.

Via Benzinga

Looking Into Huntington Ingalls Return On Invested Capital ↗

August 15, 2022

Via Benzinga

Huntington Ingalls Secures US Air Force Contract ↗

August 11, 2022

Via Benzinga

Huntington Ingalls Shares Gain After Q2 Beat ↗

August 04, 2022

Via Benzinga

HII Wins US Air Force $76.7 Million Electronic Warfare Research and Analysis Task Order

October 12, 2022

From Huntington Ingalls Industries, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

HII Bags $127M Contract To Support Defense Security Cooperation Agency ↗

August 03, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 ↗

October 11, 2022

Upgrades

Via Benzinga

HII Secures $826M Task Order To Support DOD Technology Innovation ↗

August 01, 2022

Via Benzinga

HII Secures Electromagnetic Spectrum Contract Worth $44M ↗

July 25, 2022

Via Benzinga

HII Announces Mentor-Protégé Joint Venture with Markesman Group to Accelerate Next-Generation Cybersecurity Solutions

October 10, 2022

From Huntington Ingalls Industries, Inc.

Via GlobeNewswire

Ingalls Shipbuilding Successfully Completes Acceptance Trials for Lenah Sutcliffe Higbee (DDG 123)

October 07, 2022

From Huntington Ingalls Industries, Inc.

Via GlobeNewswire

7 Defense Stocks That Are Too Cheap to Ignore ↗

October 04, 2022

Looking for defense stocks to buy at a discount? Investors shouldn't ignore these seven too-cheap-to-ignore stock picks.

Via InvestorPlace

7 Stocks That Could Survive a Market Apocalypse ↗

September 09, 2022

While no one can say for sure if a stock market crash will materialize, if one does happen, these are the companies to consider.

Via InvestorPlace

9 No-Brainer Long-Term Stocks to Buy if You Have Money to Invest ↗

August 30, 2022

With the markets taking another wrong turn, now may be a great time to strategize no-brainer long-term stocks to buy.

Via InvestorPlace

5 Dividend Growth Stocks For August 2022 ↗

August 13, 2022

Not every stock is a good buy every time. Focusing on the very best long-term ideas right now is what this video is all about.

Via Talk Markets

5 Dividend Paying Bargains In The Industrial Sector ↗

August 10, 2022

A review of five investment-grade dividend-paying growth stocks that appear attractively valued in the industrial sector.

Via Talk Markets

Time To Back Up The Ship And Buy? High-Quality Nuclear Shipbuilder That Is Looking Cheap ↗

August 09, 2022

Like the idea of getting a high-quality dividend growth stock on sale? Check out the video for full details.

Via Talk Markets

Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday ↗

August 05, 2022

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday ↗

August 05, 2022

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share...

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

Huntington Ingalls: Q2 Earnings Insights ↗

August 04, 2022

Huntington Ingalls Indus (NYSE:HII) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Via Benzinga

Huntington Ingalls Indus's Return on Invested Capital Insights ↗

May 24, 2022

According to Benzinga Pro, during Q1, Huntington Ingalls Indus (NYSE:HII) earned $140.00 million, a 16.67% increase from the preceding quarter. Huntington Ingalls Indus's sales decreased to $2.58...

Via Benzinga

3 Defense Stocks to Buy as Geopolitical Tensions Continue ↗

May 17, 2022

Defense stocks are poised to benefit from increased spending by governments as geopolitical tensions mount.

Via InvestorPlace

Jim Cramer Shares His Thoughts On AT&T, Harley-Davidson And More ↗

May 13, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said even though Harley-Davidson Inc (NYSE: HOG) is "cheap, it’s not what we want."

Via Benzinga

The 5 Best Stocks To Buy In May 2022 ↗

May 10, 2022

Today, I want to tell you my top five dividend growth stocks.

Via Talk Markets

Recap: Huntington Ingalls Indus Q1 Earnings ↗

May 05, 2022

Huntington Ingalls Indus (NYSE:HII) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.